MIM
MetLife Investment Management Portfolio holdings
AUM
$17B
1-Year Return
25.61%
This Quarter Return
+9.33%
1 Year Return
+25.61%
3 Year Return
+108.53%
5 Year Return
+194.13%
10 Year Return
–
AUM
$13.9B
AUM Growth
+$700M
(+5.3%)
Cap. Flow
-$149M
Cap. Flow
% of AUM
-1.07%
Top 10 Holdings %
Top 10 Hldgs %
27.12%
Holding
2,867
New
35
Increased
533
Reduced
1,066
Closed
81
Top Buys
| 1 |
iShares MSCI EAFE ETF
EFA
|
+$12.5M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$8.64M |
| 3 |
GE HealthCare
GEHC
|
+$7.76M |
| 4 |
Vanguard World Funds Extended Duration ETF
EDV
|
+$7.19M |
| 5 |
Aramark
ARMK
|
+$5.53M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$11.8M |
| 2 |
iShares National Muni Bond ETF
MUB
|
+$10.3M |
| 3 |
Vanguard Short-Term Bond ETF
BSV
|
+$8.83M |
| 4 |
GE Aerospace
GE
|
+$8.16M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$7.33M |
Sector Composition
| 1 | Technology | 22.35% |
| 2 | Healthcare | 12.08% |
| 3 | Financials | 10.87% |
| 4 | Consumer Discretionary | 9.84% |
| 5 | Industrials | 8.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AAT
1651
American Assets Trust
AAT
$1.26B
| $492K | ﹤0.01% |
26,466
| – | – |
|
1652
N-able
NABL
$1.55B
| $492K | ﹤0.01% |
37,268
| – | – |
|
1653
Astec Industries
ASTE
$1.07B
| $491K | ﹤0.01% |
11,909
-965
| -7% | -$39.8K |
|
1654
Arcus Biosciences
RCUS
$1.24B
| $491K | ﹤0.01% |
26,931
| – | – |
|
1655
Ecovyst
ECVT
$1.05B
| $491K | ﹤0.01% |
44,419
+8,096
| +22% | +$89.5K |
|
1656
LegalZoom.com
LZ
$1.87B
| $490K | ﹤0.01% |
52,285
| – | – |
|
1657
The GEO Group
GEO
$3.14B
| $489K | ﹤0.01% |
61,969
| – | – |
|
1658
AMERISAFE
AMSF
$852M
| $489K | ﹤0.01% |
9,986
-334
| -3% | -$16.3K |
|
1659
Geron
GERN
$842M
| $489K | ﹤0.01% |
225,163
+50,422
| +29% | +$109K |
|
1660
Adeia
ADEA
$1.69B
| $486K | ﹤0.01% |
54,813
| – | – |
|
1661
German American Bancorp
GABC
$1.52B
| $485K | ﹤0.01% |
14,537
| – | – |
|
1662
IMAX
IMAX
$1.71B
| $484K | ﹤0.01% |
25,248
-2,216
| -8% | -$42.5K |
|
1663
Winmark
WINA
$1.77B
| $484K | ﹤0.01% |
1,511
| – | – |
|
|
SWTX
1664
DELISTED
SpringWorks Therapeutics
SWTX
| $484K | ﹤0.01% |
18,797
+375
| +2% | +$9.65K |
|
|
BRKL
1665
DELISTED
Brookline Bancorp
BRKL
| $483K | ﹤0.01% |
46,045
+5,336
| +13% | +$56K |
|
|
FORG
1666
DELISTED
ForgeRock, Inc.
FORG
| $483K | ﹤0.01% |
23,469
+3,062
| +15% | +$63.1K |
|
1667
Rocket Pharmaceuticals
RCKT
$351M
| $483K | ﹤0.01% |
28,186
| – | – |
|
1668
Green Brick Partners
GRBK
$3.2B
| $482K | ﹤0.01% |
13,761
-1,169
| -8% | -$41K |
|
1669
SpartanNash
SPTN
$897M
| $482K | ﹤0.01% |
19,416
| – | – |
|
1670
Recursion Pharmaceuticals
RXRX
$2.15B
| $481K | ﹤0.01% |
72,161
| – | – |
|
1671
AdaptHealth
AHCO
$1.27B
| $481K | ﹤0.01% |
38,693
| – | – |
|
1672
Virgin Galactic
SPCE
$193M
| $481K | ﹤0.01% |
5,935
-417
| -7% | -$33.8K |
|
1673
Iovance Biotherapeutics
IOVA
$858M
| $480K | ﹤0.01% |
78,571
| – | – |
|
1674
Unitil
UTL
$831M
| $480K | ﹤0.01% |
8,412
| – | – |
|
1675
Outset Medical
OM
$246M
| $480K | ﹤0.01% |
1,738
| – | – |
|